A Crossover Trial to Examine the Efficacy of a Powder to Improve Sleep Quality and Performance

NCT07183735 | Completed

• 1 other identifier: 20417
• Study Type: interventional
• Target: 40
• Locations: 1 country
• Sites: 1

Brief Summary

This is a randomized, placebo-controlled crossover study to assess the efficacy of BEAM's Dream Powder in improving sleep health among 40 adults. Participants will use a placebo for 2 weeks, followed by the test product for 4 weeks, with sleep data collected via questionnaires and a Fitbit sleep tracker.

Conditions

Sleep; Sleep Disorder

Keywords

Sleep Quality

Outcome Measures

Primary Outcomes (2)

• Change in sleep quality as measured by the Sleep Quality Scale (SQS)

  Sleep quality will be assessed using the self-reported Sleep Quality Scale (SQS), a validated questionnaire evaluating subjective sleep quality.

  Baseline, Week 2, Week 4, Week 6

• Change in sleep quantity and architecture as measured by sleep tracker

  Objective sleep metrics (e.g., time to fall asleep, deep sleep, REM sleep, sleep transitions, sleep duration, and frequency of waking) will be collected using a sleep tracking device.

  Baseline, Week 2, Week 4, Week 6

Secondary Outcomes (5)

• Change in perceived restfulness as measured by self-reported questionnaire

  Baseline, Week 2, Week 4, Week 6

• Change in overall energy levels as measured by self-reported questionnaire

  Baseline, Week 2, Week 4, Week 6

• Change in emotional well-being as measured by self-reported questionnaire

  Baseline, Week 2, Week 4, Week 6

• Change in cognitive function as measured by self-reported questionnaire

  Baseline, Week 2, Week 4, Week 6

• Change in dietary behavior (e.g., hunger levels) as measured by self-reported questionnaire

  Baseline, Week 2, Week 4, Week 6

Study Arms (2)

BEAM Dream Powder

EXPERIMENTAL

Dietary Supplement: BEAM Dream Powder

Placebo

PLACEBO COMPARATOR

Dietary Supplement: Placebo Control

Interventions

BEAM Dream Powder DIETARY_SUPPLEMENT

A powdered sleep supplement. Administered daily, mixed with 8-12 oz hot water, 30 minutes before bedtime during Weeks 3-6.

BEAM Dream Powder

Placebo Control DIETARY_SUPPLEMENT

A powdered placebo product. Administered daily, mixed with 8-12 oz hot water, 30 minutes before bedtime during Weeks 1-2.

Placebo

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Male or female
• + years old
• Self-reported issues with sleeping, falling asleep, or staying asleep.
• Willing to discontinue any supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the study duration.
• Willing to avoid introducing any other supplements, medications, herbal remedies, or melatonin products used to assist with sleep for the duration of this trial.
• Willing to maintain their standard sleep pattern and activity level for the duration of the study.
• Be generally healthy and not live with any uncontrolled chronic disease.

You may not qualify if:

• Diagnosed with any chronic sleep condition, including but not limited to insomnia, narcolepsy, or sleep apnea.
• Women who are pregnant, breastfeeding, or trying to conceive.
• Anyone unwilling or unable to follow the study protocol.
• Any pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders.
• Is currently undergoing, or planning to undergo, any significant medical procedures during the study period.
• Has undergone any surgeries or invasive treatments in the last six months.
• A history of severe allergic reactions, including but not limited to any of the product's ingredients.
• Anyone with a nut allergy.
• Heavy drinkers. A heavy drinker is considered to be a woman who drinks 8 or more alcoholic drinks per week or a man who drinks 15 or more alcoholic drinks per week.
• Anyone who uses illicit drugs.
• Use any prescription medication, over-the-counter, or herbal remedies that can affect sleep.
• Have a job that involves working the third or night shifts.

Sponsors & Collaborators

• Beam: lead
• Citruslabs: collaborator

Study Sites (1)

Citruslabs

Las Vegas, Nevada, 89118, United States

Location

MeSH Terms

Conditions

Sleep Wake Disorders; Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Nervous System Diseases; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms; Mental Disorders; Sleep Disorders, Intrinsic; Dyssomnias

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: CROSSOVER
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 7, 2025
• First Posted: September 19, 2025
• Study Start: July 2, 2024
• Primary Completion: October 17, 2024
• Study Completion: October 17, 2024
• Last Updated: September 19, 2025

Record last verified: 2025-09

Locations

US (1)